SCHEMBL31076348

SCHEMBL31076348

CC(C)(C)OC(=O)N1CCOC(Cc2ccc(N3CCOCC3)c(Cl)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
USP2 O75604 1/20 0.44
USP30 Q70CQ3 2/20 0.43
EPHA2 P29317 2/20 0.43
ERBB2 P04626 1/20 0.43
EPHB4 P54760 1/20 0.43
AKR1C3 P42330 2/20 0.42
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
RECQL P46063 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31076333 0.89 EPHA2 (0.41) SMN1; SMN2USP30EPHA2ERBB2EPHB4
SCHEMBL31076433 0.89 EPHA2 (0.42) USP30EPHA2ERBB2EPHB4GPR119
SCHEMBL31076336 0.88 EPHA2 (0.44) SMN1; SMN2USP30EPHA2ERBB2EPHB4
SCHEMBL31076430 0.88 EPHA2 (0.44) SMN1; SMN2USP30EPHA2ERBB2EPHB4
SCHEMBL31076362 0.88 EPHA2 (0.44) SMN1; SMN2USP30EPHA2ERBB2EPHB4
SCHEMBL31076391 0.87 EPHA2 (0.45) SMN1; SMN2USP2USP30EPHA2ERBB2
SCHEMBL1552945 0.87 EPHA2 (0.44) SMN1; SMN2USP2USP30EPHA2ERBB2
SCHEMBL1551919 0.87 EPHA2 (0.44) SMN1; SMN2USP2USP30EPHA2ERBB2
SCHEMBL31076483 0.87 EPHA2 (0.44) SMN1; SMN2USP2USP30EPHA2ERBB2
SCHEMBL5222897 0.86 EPHA2 (0.44) SMN1; SMN2USP2USP30EPHA2ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642778-A1 LSD1 MODULATORS Recursion Pharmaceuticals, Inc. (US) 2025-11-05 EP disclosed
WO-2024141757-A1 LSD1 MODULATORS EXSCIENTIA AI LIMITED (GB) 2024-07-04 WO disclosed